609 related articles for article (PubMed ID: 18821775)
1. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
2. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
3. Toward the active conformations of rhodopsin and the beta2-adrenergic receptor.
Gouldson PR; Kidley NJ; Bywater RP; Psaroudakis G; Brooks HD; Diaz C; Shire D; Reynolds CA
Proteins; 2004 Jul; 56(1):67-84. PubMed ID: 15162487
[TBL] [Abstract][Full Text] [Related]
4. Drug design strategies for targeting G-protein-coupled receptors.
Klabunde T; Hessler G
Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
[TBL] [Abstract][Full Text] [Related]
5. Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops.
Kim JM; Hwa J; Garriga P; Reeves PJ; RajBhandary UL; Khorana HG
Biochemistry; 2005 Feb; 44(7):2284-92. PubMed ID: 15709741
[TBL] [Abstract][Full Text] [Related]
6. A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors.
Gouldson PR; Snell CR; Reynolds CA
J Med Chem; 1997 Nov; 40(24):3871-86. PubMed ID: 9397168
[TBL] [Abstract][Full Text] [Related]
7. PREDICT modeling and in-silico screening for G-protein coupled receptors.
Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
[TBL] [Abstract][Full Text] [Related]
8. Recognition of privileged structures by G-protein coupled receptors.
Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
[TBL] [Abstract][Full Text] [Related]
9. Ligand-binding modes in cationic biogenic amine receptors.
Ishiguro M
Chembiochem; 2004 Sep; 5(9):1210-9. PubMed ID: 15368572
[TBL] [Abstract][Full Text] [Related]
10. The third extracellular loop of G-protein-coupled receptors: more than just a linker between two important transmembrane helices.
Lawson Z; Wheatley M
Biochem Soc Trans; 2004 Dec; 32(Pt 6):1048-50. PubMed ID: 15506960
[TBL] [Abstract][Full Text] [Related]
11. Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor.
Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P
J Recept Signal Transduct Res; 1999; 19(1-4):293-300. PubMed ID: 10071765
[TBL] [Abstract][Full Text] [Related]
12. Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
Blin N; Camoin L; Maigret B; Strosberg AD
Mol Pharmacol; 1993 Dec; 44(6):1094-104. PubMed ID: 7903415
[TBL] [Abstract][Full Text] [Related]
13. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
Cavasotto CN; Orry AJ; Abagyan RA
Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
[TBL] [Abstract][Full Text] [Related]
14. X-ray crystallographic studies for ligand-protein interaction changes in rhodopsin.
Okada T
Biochem Soc Trans; 2004 Nov; 32(Pt 5):738-41. PubMed ID: 15494002
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.
Mathews II; Vanderhoff-Hanaver P; Castellino FJ; Tulinsky A
Biochemistry; 1996 Feb; 35(8):2567-76. PubMed ID: 8611560
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional models for agonist and antagonist complexes with beta 2 adrenergic receptor.
Kontoyianni M; DeWeese C; Penzotti JE; Lybrand TP
J Med Chem; 1996 Oct; 39(22):4406-20. PubMed ID: 8893835
[TBL] [Abstract][Full Text] [Related]
17. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
Filizola M; Weinstein H
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
[TBL] [Abstract][Full Text] [Related]
18. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors.
Uberti MA; Hague C; Oller H; Minneman KP; Hall RA
J Pharmacol Exp Ther; 2005 Apr; 313(1):16-23. PubMed ID: 15615865
[TBL] [Abstract][Full Text] [Related]
19. Functional immobilization of a ligand-activated G-protein-coupled receptor.
Neumann L; Wohland T; Whelan RJ; Zare RN; Kobilka BK
Chembiochem; 2002 Oct; 3(10):993-8. PubMed ID: 12362365
[TBL] [Abstract][Full Text] [Related]
20. Location and nature of the residues important for ligand recognition in G-protein coupled receptors.
Bywater RP
J Mol Recognit; 2005; 18(1):60-72. PubMed ID: 15386622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
